The upfront investment for the development of a new drug is 1 BILLION dollars.
If the FDA wants more studies, more patients in the studies and as is often the plan dictated now, life long follow up on the patients status once it is approved.
Now if the drug is not approved, a couple billion down the tubes. Understand that the FDA knows and approves each step and each study of each stage of development and clinical testing of each drug. So after a couple billion is invested, someone says, eh, sorry, no thank you.
So that money necessarily must be recouped with the success and or approval of the next drug in addition to the money invested in development of the new drug.
Understand that the drug company sees only 18 cents on the dollar of each dollar charged at the drug store. The rest goes through the stores, overhead of the store employees, shipping, government and liability insurance for each person along the chain of possession. That is the big sucker.
AND the company has 7 years to make back the investment before it goes generic.
My MS infusion is once a month and is 2200 each treatment. Biologics are especially difficult to develop.
“My MS infusion is once a month and is 2200 each treatment”
It doesn’t seem to slow you down any. Thanks for all the work you do and the guests you have on your show are awesome!